TScan Therapeutics Statistics

Total Valuation

TCRX has a market cap or net worth of $63.31 million. The enterprise value is $27.79 million.

Market Cap	63.31M
Enterprise Value	27.79M

Important Dates

The next estimated earnings date is Tuesday, August 11, 2026, before market open.

Earnings Date	Aug 11, 2026
Ex-Dividend Date	n/a

Share Statistics

TCRX has 65.35 million shares outstanding. The number of shares has increased by 6.20% in one year.

Current Share Class	61.07M
Shares Outstanding	65.35M
Shares Change (YoY)	+6.20%
Shares Change (QoQ)	+5.62%
Owned by Insiders (%)	0.18%
Owned by Institutions (%)	42.19%
Float	55.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.93
Forward PS	8.54
PB Ratio	0.60
P/TBV Ratio	0.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.65, with a Debt / Equity ratio of 0.95.

Current Ratio	6.65
Quick Ratio	6.41
Debt / Equity	0.95
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-45.59

Financial Efficiency

Return on equity (ROE) is -80.95% and return on invested capital (ROIC) is -31.89%.

Return on Equity (ROE)	-80.95%
Return on Assets (ROA)	-29.62%
Return on Invested Capital (ROIC)	-31.89%
Return on Capital Employed (ROCE)	-69.61%
Weighted Average Cost of Capital (WACC)	5.43%
Revenue Per Employee	$65,727
Profits Per Employee	-$894,281
Employee Count	139
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.09% in the last 52 weeks. The beta is 1.03, so TCRX's price volatility has been similar to the market average.

Beta (5Y)	1.03
52-Week Price Change	-37.09%
50-Day Moving Average	1.07
200-Day Moving Average	1.24
Relative Strength Index (RSI)	50.24
Average Volume (20 Days)	515,949

Short Selling Information

The latest short interest is 934,310, so 1.43% of the outstanding shares have been sold short.

Short Interest	934,310
Short Previous Month	876,559
Short % of Shares Out	1.43%
Short % of Float	1.69%
Short Ratio (days to cover)	1.43

Income Statement

In the last 12 months, TCRX had revenue of $9.14 million and -$124.31 million in losses. Loss per share was -$2.07.

Revenue	9.14M
Gross Profit	-95.53M
Operating Income	-126.70M
Pretax Income	-124.31M
Net Income	-124.31M
EBITDA	-123.82M
EBIT	-126.70M
Loss Per Share	-$2.07

Full Income Statement

Balance Sheet

The company has $128.06 million in cash and $92.54 million in debt, giving a net cash position of $35.52 million or $0.54 per share.

Cash & Cash Equivalents	128.06M
Total Debt	92.54M
Net Cash	35.52M
Net Cash Per Share	$0.54
Equity (Book Value)	96.92M
Book Value Per Share	1.61
Working Capital	112.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$122.01 million and capital expenditures -$2.95 million, giving a free cash flow of -$124.96 million.

Operating Cash Flow	-122.01M
Capital Expenditures	-2.95M
Depreciation & Amortization	2.88M
Net Borrowing	n/a
Free Cash Flow	-124.96M
FCF Per Share	-$1.91

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,386.84%
Pretax Margin	-1,360.61%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TCRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.20%
Shareholder Yield	-6.20%
Earnings Yield	-196.34%
FCF Yield	-197.37%

Analyst Forecast

The average price target for TCRX is $6.00, which is 519.32% higher than the current price. The consensus rating is "Buy".

Price Target	$6.00
Price Target Difference	519.32%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (3Y)	36.52%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TCRX has an Altman Z-Score of -4.59 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.59
Piotroski F-Score	3